Sign In
to Vote &
Create Storyboards.
 
Biosensors International has announced four- year results from the BioFreedom First in Man study (FIM), which demonstrated similar clinical outcomes between BioFreedomTM, a polymer-free drug-coated stent (DCS), and Boston Scientific's TaxusTM LibertéTM drug-eluting stent (DES), with no evidence of definite and/or probable stent thrombosis. Results were presented by Dr. Ricardo Costa, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil, at the 25th annual Transcatheter Cardiovascular T...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard